Vomaris Innovations, Inc., a regenerative medical device company specializing in microcurrent field generating technologies for the wound care market, announced a new product that is raising the bar for surgical wound care.
Featuring the company's flagship wireless microcurrent technology, Procellera HELIX Post-OpT addresses the primary healing issues of surgical incisions, offering superior antimicrobial protection and its unique microcurrents that result in reduced healing time. Recent published data has shown Procellera to have superior antimicrobial protection against real clinical wound isolates.
Applied directly over sutures, staples, steri-strips and liquid skin adhesives, Procellera HELIX Post-OpT is an "all in one" dressing that can be worn for up to 7 days post surgery. The unique shape combats the localized forces that increase the likelihood of dehiscence and increases patient comfort and mobility with its unique stress-shielding design.
"As a joint replacement surgeon, infection control and wound healing are top priorities," said Jimmy Chow, M.D., a hip and knee specialist at Hedley Orthopaedic Institute. "(Procellera) HELIX Post-OpT is a cost-effective solution that is also easier on my hospital and clinical staff. My wounds look great and my hospital, staff and patients are happy." George Swartz M.D., Orthopedic Surgeon at the Phoenix VA Medical Center commented further, "The Procellera HELIX (Post-Op)T conforms to the knee, is less bulky, and stays applied to the incision better than any product I have used before." "It's always a win for a company when its technology can set a new standard," said Michael Nagel, Vomaris@ President and CEO.
"Procellera HELIX Post-OpT addresses the market need with superior antimicrobial protection, ease of use, cost efficiency, and most importantly - an improved patient experience." About Vomaris Innovations, Inc. Vomaris Innovations, Inc., based in Chandler, Arizona, is a leading edge regenerative medical device company specializing in microcurrent field generating technologies for the wound care market. Its product, Procellera@, is the world's first self-contained antimicrobial wound dressing with microbatteries at its surface. Procellera@ is a unique device due to its inherent design with microcurrent technology. Procellera@ is indicated for over-the-counter (OTC) and professional (Rx) uses. Randomized clinical trials are in process looking at other possible wound healing benefits for the use of Procellera@.
For more information, visit http://www.vomaris.com.